Cancer Family
Meningothelial Cell Neoplasm
CI-CAN-00000263Explore in graph →
Non-malignant65 active trials2 evidence items
- NCIt
- C6971
Loading cancer entity…
Cancer Family
CI-CAN-00000263Explore in graph →
Clinical trials
185 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04298541 | Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC | withdrawn | Phase 2 | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT06012929 | A Study of ONC201 for Refractory Meningioma | withdrawn | Phase 2 | 0 | University of NebraskaOTHER | 0 | Jan 26, 2026 | clinicaltrials |
| NCT03013387 |
| Dosimetry Guided PRRT With 90Y-DOTATOC |
| withdrawn |
| Phase 2 |
| 0 |
| Sue O'DorisioOTHER |
| 0 |
| Aug 25, 2017 |
| clinicaltrials |
| NCT02194452 | Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors | withdrawn | N/A | 0 | Sue O'DorisioOTHER | 1 | Apr 28, 2017 | clinicaltrials |
| NCT00985036 | Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients | withdrawn | — | 0 | Marquette General Health SystemOTHER | 1 | Apr 24, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Aug 31, 2026source: clinicaltrials